Welcome to
Издательство Атмосфера

· Журналы
· Книги
· О проекте

·Электронные версии книг издательства “Атмосфера” поступили в продажу

Издательство “Атмосфера” идет в ногу со временем и открывает на своем сайте раздел электронных версий своих книг. Теперь вы можете приобрести не только традиционную бумажную книгу в картонном переплете, но и .pdf-файл, снабженный гиперссылками на каждую главу издания. В электронной версии проще отыскать рисунок и таблицу. Чтобы обратиться к ним, достаточно нажать на ссылку на каждый из них. Исчезла зависимость от тиража – вы можете приобрести даже те бестселлеры, тираж которых уже разошелся, такие как “Саркоидоз” или “Заболевания органов дыхания при беременности”. Упростилось получение вами книг – в течение двух рабочих дней после оплаты требуемые файлы придут на ваш e-mail. Ну и наконец, цена – электронные версии наших книг гораздо дешевле, чем бумажные издания. Заказывайте электронные версии книг издательства “Атмосфера” на сайте, а также по телефону: (495) 730-63-51 и по e-mail: atm-press2012@yandex.ru



ИНТЕРНЕТ-МАГАЗИН
Издательство Атмосфера


Телефон издательства

  
Лечебное дело
2021 / N 1

Постострый COVID-19: клинические варианты, лечебная тактика
Н.А. Шостак, Н.Г. Правдюк, Д.Ю. Андрияшкина, В.В. Смирнова

Список литературы

1. Nalbandian A, Sehgal K, Gupta A, Madhavan MV, McGroder C, Stevens JS, Cook JR, Nordvig AS, Shalev D, Sehrawat TS, Ahluwalia N, Bikdeli B, Dietz D, Der-Nigoghossian C, Liyanage-Don N, Rosner GF, Bernstein EJ, Mohan S, Beckley AA, Seres DS, Choueiri TK, Uriel N, Ausiello JC, Accili D, Freedberg DE, Baldwin M, Schwartz A, Brodie D, Garcia CK, Elkind MSV, Connors JM, Bilezikian JP, Landry DW, Wan EY. Post-acute COVID-19 syndrome. Nature Medicine 2021 Apr;27(4):601-15.
2. Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, Wang W, Song H, Huang B, Zhu N, Bi Y, Ma X, Zhan F, Wang L, Hu T, Zhou H, Hu Z, Zhou W, Zhao L, Chen J, Meng Y, Wang J, Lin Y, Yuan J, Xie Z, Ma J, Liu WJ, Wang D, Xu W, Holmes EC, Gao GF, Wu G, Chen W, Shi W, Tan W. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. The Lancet 2020 Feb;395(10224):565-74.
3. Hu B, Guo H, Zhou P, Shi ZL. Characteristics of SARS-CoV-2 and COVID-19. Nature Reviews. Microbiology 2021 Mar;19(3):141-54.
4. Chopra V, Flanders SA, O’Malley M, Malani AN, Prescott HC. Sixty-day outcomes among patients hospitalized with COVID-19. Annals of Internal Medicine 2021 Apr;174(4):576-8.
5. Arnold DT, Hamilton FW, Milne A, Morley AJ, Viner J, Attwood M, Noel A, Gunning S, Hatrick J, Hamilton S, Elvers KT, Hyams C, Bibby A, Moran E, Adamali HI, Dodd JW, Maskell NA, Barratt SL. Patient outcomes after hospitalisation with COVID-19 and implications for follow-up: results from a prospective UK cohort. Thorax 2020 Dec;76(4):399-401.
6. Moreno-Pérez O, Merino E, Leon-Ramirez JM, Andres M, Ramos JM, Arenas-Jiménez J, Asensio S, Sanchez R, Ruiz-Torregrosa P, Galan I, Scholz A, Amo A, González-delaAleja P, Boix V, Gil J; COVID19-ALC research group. Post-acute COVID-19 syndrome. Incidence and risk factors: a Mediterranean cohort study. The Journal of Infection 2021 Mar;82(3):378-83.
7. Garrigues E, Janvier P, Kherabi Y, Le Bot A, Hamon A, Gouze H, Doucet L, Berkani S, Oliosi E, Mallart E, Corre F, Zarrouk V, Moyer JD, Galy A, Honsel V, Fantin B, Nguyen Y. Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19. The Journal of Infection 2020 Dec;81(6):e4-6.
8. Евразийская ассоциация терапевтов. Персистирующие симптомы у пациентов, излечившихся от острого COVID-19. Доступно по: https://euat.ru/covid-19/publications/persistirujuschie_simptomy_u_patsientov_izlechivshihsja_ot_ostrogo_covid_19 Ссылка активна на 21.05.2021.
9. Halpin SJ, McIvor C, Whyatt G, Adams A, Harvey O, McLean L, Walshaw C, Kemp S, Corrado J, Singh R, Collins T, O’Connor RJ, Sivan M. Postdischarge symptoms and rehabilitation needs in survivors of COVID-19 infection: a cross-sectional evaluation. The Journal of Medical Virology 2021 Feb;93(2):1013-22.
10. National Institute for Health and Care Excellence (NICE). COVID-19 rapid guideline: managing the long-term effects of COVID-19. NICE guideline [NG188]. Available from: https://www.nice.org.uk/guidance/ng188 Accessed 2021 May 21.
11. Rymer W. Następstwa zdrowotne COVID-19 i nowe warianty SARS-CoV-2. Medycyna Praktyczna 2021;1:97-103.
12. Patell R, Bogue T, Koshy A, Bindal P, Merrill M, Aird WC, Bauer KA, Zwicker JI. Post-discharge thrombosis and hemorrhage in patients with COVID-19. Blood 2020 Sep;136(11):1342-6.
13. Henderson LA, Canna SW, Friedman KG, Gorelik M, Lapidus SK, Bassiri H, Behrens EM, Ferris A, Kernan KF, Schulert GS, Seo P, Son MBF, Tremoulet AH, Yeung RSM, Mudano AS, Turner AS, Karp DR, Mehta JJ. American College of Rheumatology clinical guidance for multisystem inflammatory syndrome in children associated with SARS-CoV-2 and hyperinflammation in pediatric COVID-19: version 1. Arthritis & Rheumatology 2020 Nov;72(11):1791-805.
14. McCrindle BW, RowleyAH, Newburger JW, Burns JC, Bolger AF, Gewitz M, Baker AL, Jackson MA, Takahashi M, Shah PB, Kobayashi T, Wu MH, Saji TT, Pahl E; American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee of the Council on Cardiovascular Disease in the Young; Council on Cardiovascular and Stroke Nursing; Council on Cardiovascular Surgery and Anesthesia; Council on Epidemiology and Prevention. Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association. Circulation 2017 Apr;135(17):e927-99.
15. Halpin S, O’Connor R, Sivan M. Long COVID and chronic COVID syndromes. Journal of Medical Virology 2021 Mar;93(3):1242-3.
16. Komaroff AL, Bateman L. Will COVID-19 lead to myalgic encephalomyelitis/chronic fatigue syndrome? Frontiers in Medicine 2021 Jan;7:606824.
17. Pan R, Zhang Q, Anthony SM, Zhou Y, Zou X, Cassell M, Perlman S. Oligodendrocytes that survive acute coronavirus infection induce prolonged inflammatory responses in the CNS. Proceedings of the National Academy of Sciences of the USA 2020 Jul;117(27):15902-10.
18. Wood E, Hall KH, Tate W. Role of mitochondria, oxidative stress and the response to antioxidants in myalgic encephalomyelitis/chronic fatigue syndrome: a possible approach to SARS-CoV-2 ‘long-haulers ’? Chronic Diseases and Translational Medicine 2021 Mar;7(1):14-26.
19. Можейко М.Е., Бушуева Е.В., Потанина М.В., Рябихин Е.А. Возможности лекарственной коррекции кардиогенной энцефалопатии отечественным препаратом метаболического действия. РМЖ. Медицинское обозрение 2019;4(II):49-53.
20. Чичановская Л.В., Бахарева О.Н., Сорокина К.Б. Исследование безопасности и эффективности L-карнитина у больных в раннем восстановительном периоде ишемического инсульта. Журнал неврологии и психиатрии им. С.С. Корсакова 2017;117(12-2):65-9.
21. Evangeliou A, Vlassopoulos D. Carnitine metabolism and deficit – when supplementation is necessary? Current Pharmaceutical Biotechnology 2003 Jun;4(3):211-9.
22. Speretta GF, Leite RD. Covid-19: high rates of severity and death in elderly and patients with chronic diseases reinforces the importance of regular physical activity. Sport Sciences for Health 2020 Jul 26;1-2. doi: 10.1007/s11332-020-00678-8. Online ahead of print.
23. Walsh NP, Gleeson M, Shephard RJ, Gleeson M, Woods JA, Bishop NC, Fleshner M, Green C, Pedersen BK, Hoffman-Goetz L, Rogers CJ, Northoff H, Abbasi A, Simon P. Position statement. Part one: immune function and exercise. Exercise Immunology Review 2011;17:6-63.
24. Duggal NA, Niemiro G, Harridge SDR, Simpson RJ, Lord JM. Can physical activity ameliorate immunosenescence and thereby reduce age-related multi-morbidity? Nature Reviews. Immunology 2019 Sep;19(9):563-72.
25. Tomas C, Brown A, Strassheim V, Elson J, Newton J, Manning P. Cellular bioenergetics is impaired in patients with chronic fatigue syndrome. PloS One 2017 Oct;12(10):e0186802.
26. Vermeulen RCW, Kurk RM, Visser FC, Sluiter W, Scholte HR. Patients with chronic fatigue syndrome performed worse than controls in a controlled repeated exercise study despite a normal oxidative phosphorylation capacity. Journal of Translational Medicine 2010 Oct;8:93.
27. Greenhalgh T, Knight M, A’Court C, Buxton M, Husain L. Management of post-acute covid-19 in primary care. BMJ 2020 Aug;370:m3026.

References

1. Nalbandian A, Sehgal K, Gupta A, Madhavan MV, McGroder C, Stevens JS, Cook JR, Nordvig AS, Shalev D, Sehrawat TS, Ahluwalia N, Bikdeli B, Dietz D, Der-Nigoghossian C, Liyanage-Don N, Rosner GF, Bernstein EJ, Mohan S, Beckley AA, Seres DS, Choueiri TK, Uriel N, Ausiello JC, Accili D, Freedberg DE, Baldwin M, Schwartz A, Brodie D, Garcia CK, Elkind MSV, Connors JM, Bilezikian JP, Landry DW, Wan EY. Post-acute COVID-19 syndrome. Nature Medicine 2021 Apr;27(4):601-15.
2. Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, Wang W, Song H, Huang B, Zhu N, Bi Y, Ma X, Zhan F, Wang L, Hu T, Zhou H, Hu Z, Zhou W, Zhao L, Chen J, Meng Y, Wang J, Lin Y, Yuan J, Xie Z, Ma J, Liu WJ, Wang D, Xu W, Holmes EC, Gao GF, Wu G, Chen W, Shi W, Tan W. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. The Lancet 2020 Feb;395(10224):565-74.
3. Hu B, Guo H, Zhou P, Shi ZL. Characteristics of SARS-CoV-2 and COVID-19. Nature Reviews. Microbiology 2021 Mar;19(3):141-54.
4. Chopra V, Flanders SA, O’Malley M, Malani AN, Prescott HC. Sixty-day outcomes among patients hospitalized with COVID-19. Annals of Internal Medicine 2021 Apr;174(4):576-8.
5. Arnold DT, Hamilton FW, Milne A, Morley AJ, Viner J, Attwood M, Noel A, Gunning S, Hatrick J, Hamilton S, Elvers KT, Hyams C, Bibby A, Moran E, Adamali HI, Dodd JW, Maskell NA, Barratt SL. Patient outcomes after hospitalisation with COVID-19 and implications for follow-up: results from a prospective UK cohort. Thorax 2020 Dec;76(4):399-401.
6. Moreno-Pérez O, Merino E, Leon-Ramirez JM, Andres M, Ramos JM, Arenas-Jiménez J, Asensio S, Sanchez R, Ruiz-Torregrosa P, Galan I, Scholz A, Amo A, González-delaAleja P, Boix V, Gil J; COVID19-ALC research group. Post-acute COVID-19 syndrome. Incidence and risk factors: a Mediterranean cohort study. The Journal of Infection 2021 Mar;82(3):378-83.
7. Garrigues E, Janvier P, Kherabi Y, Le Bot A, Hamon A, Gouze H, Doucet L, Berkani S, Oliosi E, Mallart E, Corre F, Zarrouk V, Moyer JD, Galy A, Honsel V, Fantin B, Nguyen Y. Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19. The Journal of Infection 2020 Dec;81(6):e4-6.
8. Eurasian Association of Therapists. Persistent symptoms in patients cured of acute COVID-19. Available from: https://euat.ru/covid-19/publications/persistirujuschie_simptomy_u_patsientov_izlechivshihsja_ot_ostrogo_covid_19 Accessed 2021 May 21(In Russian).
9. Halpin SJ, McIvor C, Whyatt G, Adams A, Harvey O, McLean L, Walshaw C, Kemp S, Corrado J, Singh R, Collins T, O’Connor RJ, Sivan M. Postdischarge symptoms and rehabilitation needs in survivors of COVID-19 infection: a cross-sectional evaluation. The Journal of Medical Virology 2021 Feb;93(2):1013-22.
10. National Institute for Health and Care Excellence (NICE). COVID-19 rapid guideline: managing the long-term effects of COVID-19. NICE guideline [NG188]. Available from: https://www.nice.org.uk/guidance/ng188 Accessed 2021 May 21.
11. Rymer W. Następstwa zdrowotne COVID-19 i nowe warianty SARS-CoV-2. Medycyna Praktyczna 2021;1:97-103.
12. Patell R, Bogue T, Koshy A, Bindal P, Merrill M, Aird WC, Bauer KA, Zwicker JI. Post-discharge thrombosis and hemorrhage in patients with COVID-19. Blood 2020 Sep;136(11):1342-6.
13. Henderson LA, Canna SW, Friedman KG, Gorelik M, Lapidus SK, Bassiri H, Behrens EM, Ferris A, Kernan KF, Schulert GS, Seo P, Son MBF, Tremoulet AH, Yeung RSM, Mudano AS, Turner AS, Karp DR, Mehta JJ. American College of Rheumatology clinical guidance for multisystem inflammatory syndrome in children associated with SARS-CoV-2 and hyperinflammation in pediatric COVID-19: version 1. Arthritis & Rheumatology 2020 Nov;72(11):1791-805.
14. McCrindle BW, RowleyAH, Newburger JW, Burns JC, Bolger AF, Gewitz M, Baker AL, Jackson MA, Takahashi M, Shah PB, Kobayashi T, Wu MH, Saji TT, Pahl E; American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee of the Council on Cardiovascular Disease in the Young; Council on Cardiovascular and Stroke Nursing; Council on Cardiovascular Surgery and Anesthesia; Council on Epidemiology and Prevention. Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association. Circulation 2017 Apr;135(17):e927-99.
15. Halpin S, O’Connor R, Sivan M. Long COVID and chronic COVID syndromes. Journal of Medical Virology 2021 Mar;93(3):1242-3.
16. Komaroff AL, Bateman L. Will COVID-19 lead to myalgic encephalomyelitis/chronic fatigue syndrome? Frontiers in Medicine 2021 Jan;7:606824.
17. Pan R, Zhang Q, Anthony SM, Zhou Y, Zou X, Cassell M, Perlman S. Oligodendrocytes that survive acute coronavirus infection induce prolonged inflammatory responses in the CNS. Proceedings of the National Academy of Sciences of the USA 2020 Jul;117(27):15902-10.
18. Wood E, Hall KH, Tate W. Role of mitochondria, oxidative stress and the response to antioxidants in myalgic encephalomyelitis/chronic fatigue syndrome: a possible approach to SARS-CoV-2 ‘long-haulers ’? Chronic Diseases and Translational Medicine 2021 Mar;7(1):14-26.
19. Mozheyko ME, Bushuyeva EV, Potanina MV, Ryabikhin EA. Correction of cardiogenic encephalopathy with domestic drug of metabolic action. Russian Medical Journal. Medical Review 2019;4(II): 49-53 (In Russian).
20. Chichanovskaya LV, Bakhareva ON, Sorokina KB. Safety and efficacy study of L-carnitine in patients with ischemic stroke in early rehabilitation period. SS Korsakov Journal of Neurology and Psychiatry 2017;117(12-2):65-9 (In Russian).
21. Evangeliou A, Vlassopoulos D. Carnitine metabolism and deficit – when supplementation is necessary? Current Pharmaceutical Biotechnology 2003 Jun;4(3):211-9.
22. Speretta GF, Leite RD. Covid-19: high rates of severity and death in elderly and patients with chronic diseases reinforces the importance of regular physical activity. Sport Sciences for Health 2020 Jul 26;1-2. doi: 10.1007/s11332-020-00678-8. Online ahead of print.
23. Walsh NP, Gleeson M, Shephard RJ, Gleeson M, Woods JA, Bishop NC, Fleshner M, Green C, Pedersen BK, Hoffman-Goetz L, Rogers CJ, Northoff H, Abbasi A, Simon P. Position statement. Part one: immune function and exercise. Exercise Immunology Review 2011;17:6-63.
24. Duggal NA, Niemiro G, Harridge SDR, Simpson RJ, Lord JM. Can physical activity ameliorate immunosenescence and thereby reduce age-related multi-morbidity? Nature Reviews. Immunology 2019 Sep;19(9):563-72.
25. Tomas C, Brown A, Strassheim V, Elson J, Newton J, Manning P. Cellular bioenergetics is impaired in patients with chronic fatigue syndrome. PloS One 2017 Oct;12(10):e0186802.
26. Vermeulen RCW, Kurk RM, Visser FC, Sluiter W, Scholte HR. Patients with chronic fatigue syndrome performed worse than controls in a controlled repeated exercise study despite a normal oxidative phosphorylation capacity. Journal of Translational Medicine 2010 Oct;8:93.
27. Greenhalgh T, Knight M, A’Court C, Buxton M, Husain L. Management of post-acute covid-19 in primary care. BMJ 2020 Aug;370:m3026.
  

[ Содержание выпуска N 1 | Выпуски журнала | Список журналов ]